An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype [clinicaltrials:NCT01528917]
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype [clinicaltrials:NCT01528917]
Bio2RDF identifier
NCT01528917
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT01528917
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This is a Natural Histo ...... Ester Storage Disease (CESD).
brief title [clinicaltrials_vocabulary:brief-title]
An Observational Study of Pati ...... ster Storage Disease Phenotype
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2013-05-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The objective of this s ...... of lipid abnormalities.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2012-02-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Acid cholesteryl ester hydrolase deficiency, type 2
Acid lipase disease
Cholesterol ester hydrolase deficiency
LAL Deficiency
LIPA Deficiency
Late Onset Lysosomal Acid Lipase (LAL) Deficiency
Lysosomal Storage Disease
Wolman disease
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-04-30T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT01528917
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
An Observational Study of the ...... ster Storage Disease Phenotype
org study id [clinicaltrials_vocabulary:org-study-id]
LAL-2-NH01
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2013-01-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2011-06-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-04-01T00:00:00Z
identifier
clinicaltrials:NCT01528917
title
An Observational Study of Pati ...... ster Storage Disease Phenotype
@en
type
label
An Observational Study of Pati ...... e [clinicaltrials:NCT01528917]
@en